Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers

Infant of Diabetic Mother Clinical Trial

Official title:
Maternal Probiotic Supplementation for Improved Neurodevelopmental Outcomes in Infants of Diabetic Mothers (IDMs)

Status Recruiting

Clinical Trial Summary

The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memory abnormalities.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05467150
Study type	Interventional
Source	University of Minnesota
Contact	Marie Hickey Swanson, MD
Phone	612-626-0644
Email	hick0245@umn.edu
Status	Recruiting
Phase	N/A
Start date	October 17, 2022
Completion date	August 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05033275` - Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy
Completed	`NCT05050058` - Echocardiographic Findings in Infants of Diabetic Mothers and Its Relation to Maternal Glycemic Control
Not yet recruiting	`NCT06111157` - Infants of Diabetic Mothers in Neonatology Unit at Assiut University Children's Hospital
Active, not recruiting	`NCT04632069` - NAC +taVNS in IDM Who Are Poor Oral Feeders	Early Phase 1
Completed	`NCT04035291` - Effectiveness of Family Collaborative Physiotherapy Programs With High-risk Infants	N/A